Pms-Sodium Polystyrene Sulfonate and Remifentanil Hydrochloride
Determining the interaction of Pms-Sodium Polystyrene Sulfonate and Remifentanil Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pms-Sodium Polystyrene Sulfonate-Remifentanil Injection
- Pms-Sodium Polystyrene Sulfonate-Remifentanil Intravenous
- Pms-Sodium Polystyrene Sulfonate-Reminyl
- Pms-Sodium Polystyrene Sulfonate-Reminyl ER
- Pms-Sodium Polystyrene Sulfonate-Remodulin
- Pms-Sodium Polystyrene Sulfonate-Remodulin injection
- Remifentanil Hydrochloride-Pneumococcal 13-valent conjugate vaccine
- Remifentanil Hydrochloride-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Remifentanil Hydrochloride-Pneumococcal Conjugate Vaccine (13-Valent)
- Remifentanil Hydrochloride-Pneumococcal Conjugate Vaccine (7-Valent)
- Remifentanil Hydrochloride-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Remifentanil Hydrochloride-Pneumococcal polysaccharides vaccine (PPSV), 23-valent